Identification of ETS-1 target genes in human fibroblasts

International Journal of Oncology

Volumn 38, Issue 6, 2011, Pages 1645-1652

  Hahne, Jens Claus ^a   Okuducu, Ali Fuat ^b   Fuchs, Tanja ^c   Florin, Alexandra ^c   Wernert, Nicolas ^c  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Angiogenesis; Ets 1; Extracellular matrix; Fibroblasts; Suppression subtractive hybridization

Indexed keywords

CATHEPSIN; DECORIN; FIBROBLAST GROWTH FACTOR; LUMICAN; PLASMINOGEN ACTIVATOR INHIBITOR 2; THIOREDOXIN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UPREGULATION; WILD TYPE;

BINDING SITES; CELL LINE; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955856913     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.981     Document Type: Article

References (49)

1. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
2. Mosher DF, Sottile J, Wu C and McDonald JA: Assembly of extracellular matrix. Curr Opin Cell Biol 4: 810-818, 1992.
3. Huxley-Jones J, Robertson DL and Boot-Handford RP: On the origins of the extracellular matrix in vertebrates. Matrix Biol 12: 855-861, 2006.
4. Lee JW and Juliano R: Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells 17: 188-202, 2004. (Pubitemid 39137065)
5. Malemud CJ: Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: 1696-1701, 2006.
6. Jodele S, Blavier L, Yoon JM and De Clerck YA: Modifying the soil to affect the seed: role of stromal-derived matrix metallo-proteinases in cancer progression. Cancer Metastasis Rev 25: 35-43, 2006. (Pubitemid 43723980)
7. Juliano RL: Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu Rev Pharmacol Toxicol 42: 283-323, 2002.
8. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
9. Bhowmick NA and Moses HL: Tumor-stroma interactions. Curr Opin Genet Dev 15: 97-101, 2005. (Pubitemid 40127637)
10. Micke P and Ostman A: Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45 (Suppl. 2): S163-S175, 2004.
11. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N: The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50, 2001.
12. Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F and Wernert N: Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth. Oncogene 24: 5384-5388, 2005. (Pubitemid 43080108)
13. Rothhammer T, Hahne JC, Florin A, Poser I, Soncin F, Wernert N and Bosserhoff AK: The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128, 2004. (Pubitemid 38121905)
14. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressoir T, Seitz G, Vandenbunder B and Stehelin D: Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5683-5688, 1994. (Pubitemid 24346267)
15. Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S and Wernert N: The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. Mini Rev Med Chem 8: 1095-1105, 2008.
16. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G and Reich R: Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway? Cancer Metastasis Rev 22: 103-115, 2003.
17. Rebrikov D, Desai S, Kogan YN, Thornton AM and Diatchenko L: Subtractive cloning: new genes for studying inflammatory disorders. Ann Periodontol 7: 17-28, 2002.
18. Rebrikov DV, Desai SM, Siebert PD and Lukyanov SA: Suppression subtractive hybridization. Methods Mol Biol 258: 107-134, 2004.
19. Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK and Trojanowska M: Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 276: 20839-20848, 2001.
20. Affara NI, Andreu P and Coussens LM: Delineating protease functions during cancer development. Methods Mol Biol 539: 1-32, 2009.
21. Arakaki PA, Marques MR and Santos MC: MMP-1 polymorphism and its relationship to pathological processes. J Biosci 34: 313-320, 2009.
22. Croucher DR, Saunders DN, Lobov S and Ranson M: Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer 8: 535-545, 2008.
23. Verma RP and Hansch C: Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 15: 2223-2268, 2007. (Pubitemid 46240907)
24. Kitamura S, Miyazaki Y, Hiraoka S, Toyota M, Nagasawa Y, Kondo S, Kiyohara T, Shinomura Y and Matsuzawa Y: PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets. Biochem Biophys Res Commun 265: 453-456, 1999.
25. Lelievre E, Lionneton F, Mattot V, Spruyt N and Soncin F: Ets-1 regulates fli-1 expression in endothelial cells. Identification of ETS binding sites in the fli-1 gene promoter. J Biol Chem 277: 25143-25151, 2002. (Pubitemid 34951820)
26. Nelson CM and Tien J: Microstructured extracellular matrices in tissue engineering and development. Curr Opin Biotechnol 17: 518-523, 2006. (Pubitemid 44442928)
27. Bissell DM, Stamatoglou SC, Nermut MV and Hughes RC: Interactions of rat hepatocytes with type IV collagen, fibronectin and laminin matrices. Distinct matrix-controlled modes of attachment and spreading. Eur J Cell Biol 40: 72-78, 1986. (Pubitemid 16103395)
28. Westermarck J and Kahari VM: Regulation of matrix metallo-proteinase expression in tumor invasion. Fasebasebasebaseb J 13: 781-792, 1999. (Pubitemid 29220691)
29. Okuducu AF, Zils U, Michaelis SA, Michaelides S and von Deimling A: Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology 48: 836-845, 2006. (Pubitemid 43800944)
30. Davidson B, Reich R, Risberg B and Nesland JM: The biological role and regulation of matrix metalloproteinases (MMP) in cancer. Arkh Patol 64: 47-53, 2002.
31. Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, Hodivala-Dilke K and Xiao Q: The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harb Symp Quant Biol 67: 143-153, 2002. (Pubitemid 36775506)
32. Eustace BK and Jay DG: Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 3: 1098-1100, 2004. (Pubitemid 40268620)
33. Kaneko T, Fujii S, Matsumoto A, Goto D, Ishimori N, Watano K, Furumoto T, Sugawara T, Sobel BE and Kitabatake A: Induction of plasminogen activator inhibitor-1 in endothelial cells by basic fibroblast growth factor and its modulation by fibric acid. Arterioscler Thromb Vasc Biol 22: 855-860, 2002. (Pubitemid 34517801)
34. Grover J, Liu CY, Kao WW and Roughley PJ: Analysis of the human lumican gene promoter. J Biol Chem 275: 40967-40973, 2000. (Pubitemid 32054921)
35. Santra M, Danielson KG and Iozzo RV: Structural and functional characterization of the human decorin gene promoter. A homopurine-homopyrimidine S1 nuclease-sensitive region is involved in transcriptional control. J Biol Chem 269: 579-587, 1994. (Pubitemid 24026698)
36. Ruoslahti E and Yamaguchi Y: Proteoglycans as modulators of growth factor activities. Cell 64: 867-869, 1991. (Pubitemid 121001173)
37. Kresse H and Schonherr E: Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189: 266-274, 2001. (Pubitemid 33063294)
38. Naito Z: Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. J Nippon Med Sch 72: 137-145, 2005.
39. Kawahata H, Kikkawa T, Higashibata Y, Sakuma T, Huening M, Sato M, Sugimoto M, Kuriyama K, Terai K, Kitamura Y and Nomura S: Enhanced expression of Runx2/PEBP2alphaA/CBFA1/AML3 during fracture healing. J Orthop Sci 8: 102-108, 2003. (Pubitemid 36240915)
40. Schmitt JM, Hwang K, Winn SR and Hollinger JO: Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17: 269-278, 1999. (Pubitemid 29190501)
41. Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, Hur SY, Kim TE and Kim JW: The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6: 74, 2006.
42. Stabile H, Mitola S, Moroni E, et al: Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 109: 1834-1840, 2007.
43. Baillat D, Begue A, Stehelin D and Aumercier M: ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. J Biol Chem 277: 29386-29398, 2002. (Pubitemid 41079222)
44. Kaminski A, Hahne JC, el Haddouti M, Florin A, Wellmann A and Wernert N: Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. Int J Mol Med 18: 941-950, 2006.
45. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC and Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704, 1990. (Pubitemid 120015135)
46. Crawford HC and Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14: 234-245, 1994.
47. Sharrocks AD: The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2: 827-837, 2001.
48. Mizui M, Isaka Y, Takabatake Y, Sato Y, Kawachi H, Shimizu F, Takahara S, Ito T and Imai E: Transcription factor Ets-1 is essential for mesangial matrix remodeling. Kidney Int 70: 298-305, 2006. (Pubitemid 44086579)
49. Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T and Kudo R: Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Gynecol Oncol 79: 256-263, 2000.